Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
It is a phase IIb, randomized, double-blind, placebo-controlled, multiple dose, multicenter treatment trial (parallel assignment) to assess efficacy and safety of SER-287 in adults with active mild-to-moderate ulcerative colitis after pre-treatment with vancomycin
Clinical Remission (Time Frame: After 10 weeks of induction dosing)
Seres Therapeutics' microbiome-based candidate SER-287 did not succeed in enhancing outcomes in a phase II trial for ulcerative colitis (1)
(1)
…